IRCT2015112821506N4
Completed
Phase 2
Comparison of the effect of vaginal Misoprostol and vaginal Isoniazid for cervical ripening prior to hysteroscopy procedures in postmenopausal and premenopausal women: Randomized Clinical Trial
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Abnormal uterine and vaginal bleeding, unspecified.
- Sponsor
- Iran University of Medical Sciences
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •postmenopausal women and premenopausal women who have no history of vaginal delivery, not pregnant at the time of examination, no contraindication for receiving prostaglandin , no severe vaginal prolapse , no previous surgery on cervix or cervical incompetence. Exclusion criteria: history of vaginal delivery, pregnancy, severe vaginal prolapse, previous surgery on cervix, history of cervical insufficiency, simultaneous laparoscopy and cervical myoma.
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Comparison of the effect of vaginal misoprostol and evening primrose oil capsules with misoprostol alone on the consequences of abortion in women with intrauterine fetal deaththe consequences of abortion in women with intrauterine fetal death.Medical abortion : complete or unspecified, without complicationO04.9IRCT20181207041873N3Iran University of Medical Sciences84
Completed
Phase 2
Comparison of the Effect of Vaginal misoprostol with Oxytocin for the management pregnancy terminations with IUFDIRCT20181218042033N2Bandare-abbas University of Medical Sciences106
Recruiting
Phase 3
The Effect of Laminaria with Vaginal Misoprostol on Cervical Preparation in Induction of Second Trimester AbortioIRCT20190529043759N1Zahedan University of Medical Sciences90
Recruiting
Phase 3
Comparison of the effect of vaginal misoprostol and Evening primrose Capsule on the state of deliveryormal Vaginal Delivery.IRCT20210113050028N2Ardabil University of Medical Sciences30
Completed
Not Applicable
A comparison of vaginal misoprostol versus vaginal misoprostol and nitric oxide donor for termination of pregnancy at 13 to 29 weeks. A prospective randomised trialISRCTN44341343Farhat Hached University Teaching Hospital (Tunisia)70